Matches in Wikidata for { <http://www.wikidata.org/entity/Q101236591> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- Q101236591 description "article scientifique publié en 2020" @default.
- Q101236591 description "artículu científicu espublizáu n'ochobre de 2020" @default.
- Q101236591 description "scientific article published on 26 October 2020" @default.
- Q101236591 description "wetenschappelijk artikel" @default.
- Q101236591 description "наукова стаття, опублікована 26 жовтня 2020" @default.
- Q101236591 name "Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial" @default.
- Q101236591 name "Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial" @default.
- Q101236591 name "Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial" @default.
- Q101236591 type Item @default.
- Q101236591 label "Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial" @default.
- Q101236591 label "Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial" @default.
- Q101236591 label "Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial" @default.
- Q101236591 prefLabel "Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial" @default.
- Q101236591 prefLabel "Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial" @default.
- Q101236591 prefLabel "Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial" @default.
- Q101236591 P1433 Q101236591-9A175E5F-90BC-4752-A12F-46123B7B2C57 @default.
- Q101236591 P1476 Q101236591-59ED630D-E984-4443-9358-2B2534FF7B37 @default.
- Q101236591 P2093 Q101236591-17CB5F69-1B9B-4425-9733-974CAEF3CCDE @default.
- Q101236591 P2093 Q101236591-588B4FA4-EE67-4DF0-9417-8BD74F361980 @default.
- Q101236591 P2093 Q101236591-64B7E9B5-61C9-4300-A8FD-559EF86EF6C2 @default.
- Q101236591 P2093 Q101236591-81E4D2C9-3F85-4C17-8753-0C082C55CB85 @default.
- Q101236591 P2093 Q101236591-A0EC75BA-729C-451E-8398-87A457469299 @default.
- Q101236591 P2093 Q101236591-A8C49E29-FCF3-466B-83EA-7E5F086E16F7 @default.
- Q101236591 P2093 Q101236591-AEBE2965-E2F3-4D7B-821C-43AF858402EE @default.
- Q101236591 P2093 Q101236591-CAB861F5-F169-4756-B266-35C1835DE9B8 @default.
- Q101236591 P2093 Q101236591-DBAC19CE-53E7-4CC8-BE1B-B5ACA68C0FFE @default.
- Q101236591 P2093 Q101236591-EAF2007C-6B85-448C-93EF-0A9410B10894 @default.
- Q101236591 P304 Q101236591-618F5FE5-DBF0-47DE-A344-7702E3FEA11C @default.
- Q101236591 P31 Q101236591-CFC104E5-0BE4-4FFE-96BC-93872E2AE91B @default.
- Q101236591 P356 Q101236591-EE1367AB-52E0-44F1-B6D8-FD129917F1D6 @default.
- Q101236591 P433 Q101236591-3AD86652-74EA-4769-970D-04CF43495861 @default.
- Q101236591 P478 Q101236591-7E95317B-8DE9-4250-994B-A233107BFF80 @default.
- Q101236591 P50 Q101236591-795A180B-2655-445D-A703-0A4A5EA362E8 @default.
- Q101236591 P577 Q101236591-787BB8BB-6765-41E3-A41D-9EF73B566690 @default.
- Q101236591 P698 Q101236591-824F752A-93E7-4B9A-876C-25D3D1658B7B @default.
- Q101236591 P921 Q101236591-7FB920C2-8935-4CA4-B6AD-A061C493A6DE @default.
- Q101236591 P921 Q101236591-85DCF569-F50B-4567-AC90-46C6B56663DD @default.
- Q101236591 P921 Q101236591-ADB263E5-EC21-40AD-8431-0A518E41A413 @default.
- Q101236591 P932 Q101236591-A3498356-182F-4556-BB95-80649CDD80B4 @default.
- Q101236591 P356 S13063-020-04734-Z @default.
- Q101236591 P698 33106167 @default.
- Q101236591 P1433 Q7840023 @default.
- Q101236591 P1476 "Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial" @default.
- Q101236591 P2093 "Abdur Rahim" @default.
- Q101236591 P2093 "Ashraful Hoque" @default.
- Q101236591 P2093 "Forhad Uddin Hasan Chowdhury" @default.
- Q101236591 P2093 "M Mujibur Rahman" @default.
- Q101236591 P2093 "Md Abul Kalam" @default.
- Q101236591 P2093 "Md Robed Amin" @default.
- Q101236591 P2093 "Md Ruhul Amin" @default.
- Q101236591 P2093 "Md Sayedur Rahman" @default.
- Q101236591 P2093 "Md Titu Miah" @default.
- Q101236591 P2093 "Rubina Yasmin" @default.
- Q101236591 P304 "883" @default.
- Q101236591 P31 Q13442814 @default.
- Q101236591 P356 "10.1186/S13063-020-04734-Z" @default.
- Q101236591 P433 "1" @default.
- Q101236591 P478 "21" @default.
- Q101236591 P50 Q47502278 @default.
- Q101236591 P577 "2020-10-26T00:00:00Z" @default.
- Q101236591 P698 "33106167" @default.
- Q101236591 P921 Q105209484 @default.
- Q101236591 P921 Q111908491 @default.
- Q101236591 P921 Q84263196 @default.
- Q101236591 P932 "7586693" @default.